Tolcapone
1 NDC across 1 manufacturer|0 Generic,1 Brand
Tolcapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 29, 1998, and the first generic was approved Mar 26, 2015. In 2024, Medicare Part D spent $484K on Tolcapone across 138 claims for 20 beneficiaries.
Tolcapone is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $105.98 to $105.98 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$105.98 – $105.98
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TOLCAPONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TASMAR 100 MG TABLET | $105.9846 per EA | — |
Frequently Asked Questions
What is Tolcapone used to treat?
Tolcapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Tolcapone become available as a generic?
FDA approved the first generic Tolcapone (ANDA) on Mar 26, 2015.
How much does Medicare spend on Tolcapone?
In 2024, Medicare Part D spent $484K on Tolcapone across 138 claims for 20 beneficiaries.
How many Tolcapone products are on the market?
The Tolcapone drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Tolcapone?
NADAC reference prices for Tolcapone range from $105.9846 to $105.9846 per EA.
Which manufacturers make Tolcapone?
1 manufacturer lists Tolcapone in NADAC. Ranked by number of NDCs, the largest are Bausch Health US LLC (1).